Early administration of intravenous tissue plasminogen activator (IV-tPA) and/or endovascular therapy (EVT) is associated with improved outcomes in acute ischemic stroke (AIS) (1, 2). This evidence concerns the gene PLAT and androgen insensitivity syndrome.